Mitoxantrone Etoposide and Cytarabine (MEC) Plus Lenalidomide for Relapsed or Refractory Acute Myeloid Leukemia
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Age: Between 18 - 70 Years
Gender: Male or Female
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required